Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.
Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grünewald RA, Kasteleijn-Nolst Trenite DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S. Panayiotopoulos CP, et al. Among authors: parker ap. Epilepsia. 2004 Dec;45(12):1646-9; author reply 1649-51. doi: 10.1111/j.0013-9580.2004.32404_1.x. Epilepsia. 2004. PMID: 15571526 Free article. No abstract available.
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grünewald RA, Kasteleijn-Nolst Trenité DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S. Panayiotopoulos CP, et al. Among authors: parker ap. Neurology. 2005 Jan 11;64(1):172-4; author reply 172-4. Neurology. 2005. PMID: 15645539 No abstract available.
Vigabatrin aggravates absences and absence status.
Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP. Panayiotopoulos CP, et al. Among authors: parker ap. Neurology. 1997 Nov;49(5):1467. doi: 10.1212/wnl.49.5.1467. Neurology. 1997. PMID: 9371946 No abstract available.
Vagal nerve stimulation in epileptic encephalopathies.
Parker AP, Polkey CE, Binnie CD, Madigan C, Ferrie CD, Robinson RO. Parker AP, et al. Pediatrics. 1999 Apr;103(4 Pt 1):778-82. doi: 10.1542/peds.103.4.778. Pediatrics. 1999. PMID: 10103302 Clinical Trial.
Ketogenic diet registry for epilepsy: A cross-sectional feasibility study.
Neal EG, Whiteley VJ, van der Louw E, Devlin AM, Eltze C, Pujar S, Simpson Z, Hardy I, Palmer A, Szmurlo A, Parker AP, Mills N, Ord R, Lagae L, Kerckhove KV, van den Berg S, Cross JH, Schoeler NE. Neal EG, et al. Among authors: parker ap. Eur J Paediatr Neurol. 2024 Nov;53:131-137. doi: 10.1016/j.ejpn.2024.10.011. Epub 2024 Oct 28. Eur J Paediatr Neurol. 2024. PMID: 39504880 Free article.
Editorial: Advances in Early Onset Epilepsies.
Parker APJ, Hartmann H, Van Bogaert P. Parker APJ, et al. Front Neurol. 2021 Jul 15;12:709213. doi: 10.3389/fneur.2021.709213. eCollection 2021. Front Neurol. 2021. PMID: 34335459 Free PMC article. No abstract available.
38 results